Inhibition	O
of	O
the	O
differentiation	O
of	O
human	B-cell_line
myeloid	I-cell_line
cell	I-cell_line
lines	I-cell_line
by	O
redox	O
changes	O
induced	O
through	O
glutathione	O
depletion	O
.	O

We	O
have	O
investigated	O
the	O
effect	O
of	O
redox	O
changes	O
in	O
vivo	O
on	O
the	O
differentiation	O
of	O
two	O
human	B-cell_line
myeloid	I-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
HL-60	B-cell_line
and	O
KG-1	B-cell_line
.	O

The	O
glutathione-depleting	O
agent	O
diethyl	O
maleate	O
(	O
DEM	O
)	O
prevented	O
the	O
development	O
of	O
differentiated	O
features	O
in	O
response	O
to	O
phorbol	O
esters	O
,	O
including	O
adherence	O
of	O
the	O
cells	O
to	O
plastic	O
surfaces	O
and	O
repression	O
of	O
the	O
myeloperoxidase	B-DNA
and	I-DNA
CD34	I-DNA
genes	I-DNA
.	O

Moreover	O
,	O
DEM	O
abolished	O
phorbol	O
12-myristate	O
13-acetate-induced	O
activation	O
of	O
the	O
transcription	B-protein
factors	I-protein
AP-1	B-protein
and	O
Egr-1	B-protein
,	O
suggesting	O
that	O
inhibition	O
of	O
differentiation	O
may	O
be	O
due	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
redox	O
modifications	O
of	O
these	O
proteins	B-protein
.	O

Biochem	NULL
.	NULL

J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
301	NULL
,	NULL
649-653	NULL
(	NULL
Printed	NULL
in	NULL
Great	NULL
Britain	NULL
)	NULL
649	NULL
RESEARCH	NULL
COMMUNICATION	NULL
Inhibition	NULL
of	NULL
the	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
by	NULL
redox	NULL
changes	NULL
induced	NULL
through	NULL
glutathione	NULL
depletion	NULL
Franca	NULL
ESPOSITO	NULL
,	NULL
*	NULL
Valter	NULL
AGOSTI	NULL
,	NULL
*	NULL
Giovanni	NULL
MORRONE	NULL
,	NULL
*f	NULL
Fernando	NULL
MORRA	NULL
,	NULL
*	NULL
Cristina	NULL
CUOMO	NULL
,	NULL
*	NULL
Tommaso	NULL
RUSSO	NULL
,	NULL
*	NULL
Salvatore	NULL
VENUTAt	NULL
and	NULL
Filiberto	NULL
CIMINO*t	NULL
*Dipartimento	NULL
di	NULL
Biochemica	NULL
e	NULL
Biotecnologie	NULL
Mediche	NULL
,	NULL
Universita	NULL
degli	NULL
Studi	NULL
di	NULL
Napoli	NULL
Federico	NULL
II	NULL
'	NULL
,	NULL
Via	NULL
S.	NULL
Pansini	NULL
,	NULL
5	NULL
,	NULL
1-80131	NULL
Napoli	NULL
,	NULL
and	NULL
di	NULL
Medicina	NULL
Sperimentale	NULL
e	NULL
Clinica	NULL
,	NULL
Universita	NULL
delgi	NULL
Studi	NULL
de	NULL
Reggio	NULL
Calabria	NULL
,	NULL
Via	NULL
T.	NULL
Campanella	NULL
,	NULL
1-88100	NULL
Catanzaro	NULL
,	NULL
Italy	NULL
We	NULL
have	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
redox	NULL
changes	NULL
in	NULL
vivo	NULL
on	NULL
the	NULL
differentiation	NULL
of	NULL
two	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
HL-60	NULL
and	NULL
KG-1	NULL
.	NULL

The	NULL
glutathione-depleting	NULL
agent	NULL
diethyl	NULL
maleate	NULL
(	NULL
DEM	NULL
)	NULL
prevented	NULL
the	NULL
development	NULL
of	NULL
differentiated	NULL
features	NULL
in	NULL
response	NULL
to	NULL
phorbol	NULL
esters	NULL
,	NULL
including	NULL
adherence	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
plastic	NULL
surfaces	NULL
and	NULL
repression	NULL
of	NULL
the	NULL
myeloperoxidase	NULL
and	NULL
CD34	NULL
genes	NULL
.	NULL

More-over	NULL
,	NULL
DEM	NULL
abolished	NULL
phorbol	NULL
12-myristate	NULL
13-acetate-induced	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
and	NULL
Egr-1	NULL
,	NULL
suggesting	NULL
that	NULL
inhibition	NULL
of	NULL
differentiation	NULL
may	NULL
be	NULL
due	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
to	NULL
redox	NULL
modifications	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
maintenance	NULL
of	NULL
the	NULL
haematopoietic	NULL
system	NULL
is	NULL
ensured	NULL
by	NULL
differentiation	NULL
of	NULL
multipotent	NULL
progenitors	NULL
along	NULL
one	NULL
or	NULL
multiple	NULL
lineages	NULL
,	NULL
generating	NULL
the	NULL
different	NULL
mature	NULL
cell	NULL
populations	NULL
of	NULL
the	NULL
peripheral	NULL
blood	NULL
[	NULL
1	NULL
]	NULL
.	NULL

Binding	NULL
of	NULL
haemopoietic	NULL
cytokines	NULL
to	NULL
specific	NULL
cell	NULL
surface	NULL
receptors	NULL
triggers	NULL
intracellular	NULL
transduction	NULL
pathways	NULL
that	NULL
in	NULL
turn	NULL
induce	NULL
co-ordinate	NULL
expression	NULL
of	NULL
regulatory	NULL
genes	NULL
through	NULL
activation	NULL
of	NULL
specific	NULL
transcription	NULL
factors	NULL
.	NULL

This	NULL
results	NULL
in	NULL
the	NULL
commitment	NULL
of	NULL
multipotent	NULL
progenitors	NULL
to	NULL
terminal	NULL
differentiation	NULL
.	NULL

A	NULL
number	NULL
of	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
which	NULL
resemble	NULL
to	NULL
some	NULL
extent	NULL
haematopoietic	NULL
progenitors	NULL
,	NULL
which	NULL
may	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
in	NULL
vitro	NULL
and	NULL
whose	NULL
maturation	NULL
can	NULL
be	NULL
accurately	NULL
monitored	NULL
,	NULL
have	NULL
been	NULL
employed	NULL
in	NULL
biochemical	NULL
and	NULL
molecular	NULL
studies	NULL
of	NULL
myeloid	NULL
differentiation	NULL
[	NULL
2	NULL
]	NULL
.	NULL

Among	NULL
the	NULL
best	NULL
known	NULL
myeloid	NULL
cell	NULL
lines	NULL
are	NULL
the	NULL
promyelocytic	NULL
HL-60	NULL
and	NULL
the	NULL
myeloblastic	NULL
KG-1	NULL
.	NULL

The	NULL
HL-60	NULL
line	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
cells	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
myeloid	NULL
leukaemia	NULL
type	NULL
M2	NULL
,	NULL
and	NULL
exhibits	NULL
several	NULL
features	NULL
of	NULL
normal	NULL
human	NULL
promyelocytes	NULL
.	NULL

When	NULL
exposed	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
chemicals	NULL
,	NULL
vitamins	NULL
or	NULL
cytokines	NULL
,	NULL
these	NULL
cells	NULL
differentiate	NULL
towards	NULL
granulocytes	NULL
or	NULL
monocytes	NULL
[	NULL
3,4	NULL
]	NULL
.	NULL

Suitable	NULL
markers	NULL
for	NULL
evaluating	NULL
HL-60	NULL
maturation	NULL
include	NULL
the	NULL
expression	NULL
of	NULL
two	NULL
genes	NULL
,	NULL
those	NULL
for	NULL
myeloperoxidase	NULL
(	NULL
MPO	NULL
)	NULL
,	NULL
which	NULL
is	NULL
down-regulated	NULL
in	NULL
differentiated	NULL
cells	NULL
[	NULL
5	NULL
]	NULL
,	NULL
and	NULL
lysozyme	NULL
,	NULL
which	NULL
is	NULL
greatly	NULL
increased	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
[	NULL
6	NULL
]	NULL
.	NULL

The	NULL
KG-1	NULL
cell	NULL
line	NULL
,	NULL
established	NULL
from	NULL
the	NULL
bone	NULL
marrow	NULL
cells	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
erythroid	NULL
leukaemia	NULL
[	NULL
7	NULL
]	NULL
,	NULL
shows	NULL
immature	NULL
characteristics	NULL
,	NULL
such	NULL
as	NULL
expression	NULL
of	NULL
the	NULL
progenitor-related	NULL
CD34	NULL
antigen	NULL
.	NULL

However	NULL
,	NULL
the	NULL
differentiation	NULL
potential	NULL
of	NULL
this	NULL
cell	NULL
line	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
monocyte/	NULL
macrophage	NULL
lineage	NULL
.	NULL

Such	NULL
differentiation	NULL
can	NULL
be	NULL
achieved	NULL
by	NULL
phorbol	NULL
ester	NULL
treatment	NULL
,	NULL
and	NULL
is	NULL
accompanied	NULL
by	NULL
a	NULL
drastic	NULL
decline	NULL
in	NULL
the	NULL
level	NULL
of	NULL
the	NULL
CD34	NULL
transcript	NULL
[	NULL
8	NULL
]	NULL
.	NULL

The	NULL
study	NULL
of	NULL
myeloid	NULL
cell	NULL
lines	NULL
has	NULL
led	NULL
to	NULL
the	NULL
discovery	NULL
of	NULL
a	NULL
number	NULL
of	NULL
DNA-binding	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
haematopoietic	NULL
differentiation	NULL
[	NULL
9-11	NULL
]	NULL
.	NULL

A	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
,	NULL
Egr-1	NULL
,	NULL
has	NULL
been	NULL
discovered	NULL
to	NULL
be	NULL
of	NULL
crucial	NULL
importance	NULL
in	NULL
the	NULL
commitment	NULL
of	NULL
myeloid	NULL
progenitors	NULL
towards	NULL
monocyte	NULL
restricted	NULL
differentiation	NULL
.	NULL

Egr-1	NULL
is	NULL
strictly	NULL
required	NULL
for	NULL
maturation	NULL
of	NULL
HL-60	NULL
cells	NULL
to	NULL
monocytes	NULL
following	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
treatment	NULL
,	NULL
as	NULL
well	NULL
as	NULL
for	NULL
differentiation	NULL
of	NULL
bone	NULL
marrow	NULL
monocyte	NULL
precursors	NULL
in	NULL
response	NULL
to	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

An	NULL
HL-60	NULL
subclone	NULL
constitutively	NULL
expressing	NULL
Egr-1	NULL
became	NULL
incapable	NULL
of	NULL
granulocytic	NULL
differentiation	NULL
[	NULL
12	NULL
]	NULL
.	NULL

This	NULL
factor	NULL
is	NULL
therefore	NULL
a	NULL
useful	NULL
tool	NULL
for	NULL
the	NULL
study	NULL
of	NULL
the	NULL
monocytic	NULL
pathway	NULL
.	NULL

Following	NULL
a	NULL
number	NULL
of	NULL
reports	NULL
on	NULL
the	NULL
involvement	NULL
of	NULL
redox	NULL
modifications	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
their	NULL
DNA-binding	NULL
activity	NULL
in	NULL
vitro	NULL
,	NULL
we	NULL
became	NULL
interested	NULL
in	NULL
testing	NULL
the	NULL
in	NULL
vivo	NULL
effect	NULL
of	NULL
agents	NULL
that	NULL
may	NULL
affect	NULL
the	NULL
redox	NULL
status	NULL
of	NULL
such	NULL
factors	NULL
,	NULL
using	NULL
differentiation-inducible	NULL
myeloid	NULL
cell	NULL
lines	NULL
as	NULL
a	NULL
suitable	NULL
experimental	NULL
model	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
glutathione	NULL
depletion	NULL
induced	NULL
by	NULL
diethyl	NULL
maleate	NULL
(	NULL
DEM	NULL
)	NULL
counteracts	NULL
the	NULL
PMA-stimulated	NULL
monocytic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
and	NULL
KG-1	NULL
cells	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
molecular	NULL
as	NULL
well	NULL
as	NULL
morphological	NULL
criteria	NULL
.	NULL

This	NULL
inhibitory	NULL
effect	NULL
appears	NULL
to	NULL
be	NULL
reversible	NULL
upon	NULL
withdrawal	NULL
of	NULL
the	NULL
oxidizing	NULL
agent	NULL
,	NULL
and	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
lack	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
and	NULL
Egr-1	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
stimulation	NULL
HL-60	NULL
and	NULL
KG-1	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Flow	NULL
Laboratories	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
foetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
,	NULL
U.S.A.	NULL
)	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
!	NULL

streptomycin	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
(	NULL
Flow	NULL
)	NULL
.	NULL

PMA	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

For	NULL
stimulation	NULL
of	NULL
differentiation	NULL
,	NULL
KG-1	NULL
cells	NULL
were	NULL
maintained	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
nM	NULL
PMA	NULL
,	NULL
whereas	NULL
HL-60	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
nM	NULL
PMA	NULL
.	NULL

DEM	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
used	NULL
at	NULL
1	NULL
mM	NULL
final	NULL
concentration	NULL
unless	NULL
otherwise	NULL
indicated	NULL
.	NULL

Intracellular	NULL
GSH	NULL
depletion	NULL
was	NULL
measured	NULL
by	NULL
an	NULL
h.p.l.c	NULL
.	NULL

procedure	NULL
as	NULL
described	NULL
[	NULL
13	NULL
]	NULL
;	NULL
cell	NULL
viability	NULL
after	NULL
the	NULL
treatments	NULL
was	NULL
assessed	NULL
by	NULL
Trypan	NULL
Blue	NULL
exclusion	NULL
.	NULL

Cell	NULL
proliferation	NULL
was	NULL
evaluated	NULL
by	NULL
measuring	NULL
[	NULL
HJthymidine	NULL
incorporation	NULL
into	NULL
the	NULL
cellular	NULL
DNA	NULL
.	NULL

Abbreviations	NULL
used	NULL
:	NULL
DEM	NULL
,	NULL
diethyl	NULL
maleate	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
MPO	NULL
,	NULL
myeloperoxidase	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
PMSF	NULL
,	NULL
phenylmethanesulphonyl	NULL
!	NULL

fluoride	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcription-PCR	NULL
;	NULL
TRE	NULL
,	NULL
PMA	NULL
(	NULL
TPA	NULL
)	NULL
-responsive	NULL
element	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

650	NULL
Research	NULL
Communication	NULL
Northern	NULL
blot	NULL
analysis	NULL
For	NULL
RNA	NULL
preparation	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
3	NULL
ml	NULL
of	NULL
guanidinium	NULL
thiocyanate	NULL
buffer	NULL
and	NULL
subjected	NULL
to	NULL
phenol/chloroform	NULL
extraction	NULL
as	NULL
described	NULL
by	NULL
Chomezynsky	NULL
and	NULL
Sacchi	NULL
[	NULL
14	NULL
]	NULL
.	NULL

Samples	NULL
of	NULL
10-15	NULL
ug	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
were	NULL
electrophoresed	NULL
on	NULL
1.5	NULL
%	NULL
agarose/formaldehyde	NULL
gels	NULL
and	NULL
transferred	NULL
on	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
Nytran	NULL
;	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
,	NULL
Dassel	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
incubated	NULL
at	NULL
80	NULL
°C	NULL
for	NULL
2	NULL
h	NULL
under	NULL
vacuum	NULL
,	NULL
hybridized	NULL
for	NULL
16h	NULL
at	NULL
65°C	NULL
with	NULL
10-30	NULL
Ci	NULL
of	NULL
radiolabelled	NULL
probes	NULL
,	NULL
extensively	NULL
washed	NULL
and	NULL
autoradiographed	NULL
with	NULL
X-ray	NULL
film	NULL
(	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

Molecular	NULL
probes	NULL
were	NULL
generated	NULL
by	NULL
reverse	NULL
transcription-PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
:	NULL
cDNA	NULL
was	NULL
synthesized	NULL
from	NULL
approx	NULL
.	NULL

2	NULL
ug	NULL
of	NULL
cellular	NULL
RNA	NULL
using	NULL
Superscript	NULL
reverse	NULL
transcriptase	NULL
(	NULL
BRL	NULL
Life	NULL
Tecnologies	NULL
G.m.b.H	NULL
.	NULL

,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
random	NULL
hexamers	NULL
(	NULL
0.5-2.5	NULL
uM	NULL
;	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
as	NULL
primers	NULL
.	NULL

cDNA	NULL
was	NULL
subjected	NULL
to	NULL
30	NULL
cycles	NULL
of	NULL
PCR	NULL
amplification	NULL
using	NULL
the	NULL
oligonucleotides	NULL
described	NULL
below	NULL
.	NULL

These	NULL
were	NULL
designed	NULL
in	NULL
order	NULL
to	NULL
obtain	NULL
similar	NULL
melting	NULL
temperature	NULL
(	NULL
7	NULL
)	NULL
and	NULL
PCR	NULL
products	NULL
of	NULL
comparable	NULL
size	NULL
.	NULL

After	NULL
analytical	NULL
digestion	NULL
with	NULL
specific	NULL
restriction	NULL
enzymes	NULL
to	NULL
verify	NULL
the	NULL
faithfulness	NULL
of	NULL
amplification	NULL
,	NULL
PCR	NULL
products	NULL
were	NULL
purified	NULL
(	NULL
Qiaex	NULL
;	NULL
Qiagen	NULL
Inc.	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
,	NULL
U.S.A.	NULL
)	NULL
from	NULL
agarose	NULL
gels	NULL
and	NULL
amplified	NULL
by	NULL
10	NULL
PCR	NULL
cycles	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
40	NULL
Ci	NULL
of	NULL
[	NULL
«	NULL
-	NULL
``	NULL
°P	NULL
]	NULL
dATP	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

Labelled	NULL
probes	NULL
were	NULL
separated	NULL
from	NULL
non-incorporated	NULL
[	NULL
«	NULL
-**P	NULL
]	NULL
dATP	NULL
on	NULL
G-50	NULL
columns	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

Taq	NULL
polymerase	NULL
was	NULL
from	NULL
Perkin	NULL
Elmer	NULL
(	NULL
Vaterstetten	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
primers	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
MPO	NULL
:	NULL
forward	NULL
(	NULL
nucleotides	NULL
1069-1086	NULL
)	NULL
,	NULL
5	NULL
CCCA-ATGACCCCCGCATC	NULL
3	NULL
'	NULL
;	NULL
reverse	NULL
(	NULL
nucleotides	NULL
1387-1369	NULL
)	NULL
,	NULL
5	NULL
TGTCCCCTGCCAGGAAGCA	NULL
3	NULL
;	NULL
CD34	NULL
:	NULL
forward	NULL
(	NULL
nucleotides	NULL
811-830	NULL
)	NULL
,	NULL
5°	NULL
TGACTCAGGGCATCTGCCTG	NULL
3	NULL
'	NULL
;	NULL
reverse	NULL
(	NULL
nucleotides	NULL
1206-1225	NULL
)	NULL
,	NULL
5°	NULL
CTTTCTCCTGTGGGGCTCCA	NULL
3	NULL
'	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
HL-60	NULL
cells	NULL
according	NULL
to	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

[	NULL
15	NULL
]	NULL
with	NULL
slight	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
HL-60	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10/100	NULL
mm	NULL
plastic	NULL
dish	NULL
)	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
10	NULL
ml	NULL
of	NULL
TBS	NULL
(	NULL
58.44	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
85.55	NULL
mM	NULL
NaCl	NULL
)	NULL
and	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
1500	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
0	NULL
°C	NULL
.	NULL

The	NULL
pellets	NULL
were	NULL
gently	NULL
resuspended	NULL
in	NULL
400	NULL
1	NULL
of	NULL
ice-cold	NULL
buffer	NULL
A	NULL
[	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
and	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithio-threitol	NULL
(	NULL
DTT	NULL
)	NULL
and	NULL
0.5	NULL
mM	NULL
phenylmethanesulphonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
freshly	NULL
prepared	NULL
,	NULL
were	NULL
added	NULL
at	NULL
the	NULL
last	NULL
moment	NULL
]	NULL
.	NULL

After	NULL
swelling	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
25	NULL
wl	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P40	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
;	NULL
the	NULL
samples	NULL
were	NULL
vortexed	NULL
for	NULL
10	NULL
s	NULL
and	NULL
centrifuged	NULL
for	NULL
30	NULL
s	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Nuclear	NULL
pellets	NULL
were	NULL
subsequently	NULL
resuspended	NULL
in	NULL
30	NULL
ul	NULL
of	NULL
ice-cold	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
and	NULL
1	NULL
mM	NULL
PMSF	NULL
)	NULL
,	NULL
rocked	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
and	NULL
centrifuged	NULL
at	NULL
15000	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Supernatants	NULL
were	NULL
collected	NULL
and	NULL
stored	NULL
in	NULL
aliquots	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
The	NULL
PMA-responsive	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
and	NULL
Egr-1	NULL
probes	NULL
used	NULL
for	NULL
EMSA	NULL
were	NULL
prepared	NULL
by	NULL
labelling	NULL
1	NULL
pmol	NULL
of	NULL
double-stranded	NULL
oligonucleotides	NULL
,	NULL
using	NULL
16	NULL
units	NULL
of	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
,	NULL
U.S.A.	NULL
)	NULL
and	NULL
40	NULL
Ci	NULL
of	NULL
[	NULL
y-**P	NULL
]	NULL
JATP	NULL
(	NULL
Amersham	NULL
)	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
labelled	NULL
oligonucleotides	NULL
were	NULL
purified	NULL
from	NULL
non-denaturing	NULL
12	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

A	NULL
sample	NULL
containing	NULL
(	NULL
20-40	NULL
)	NULL
x	NULL
10°	NULL
c.p.m	NULL
.	NULL

of	NULL
the	NULL
eluted	NULL
radioactivity	NULL
(	NULL
corresponding	NULL
to	NULL
approx	NULL
.	NULL

1	NULL
fmol	NULL
of	NULL
DNA	NULL
)	NULL
was	NULL
used	NULL
for	NULL
each	NULL
reaction	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
follows	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
g	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
18	NULL
wl	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
100	NULL
mM	NULL
KCl	NULL
,	NULL
2	NULL
%	NULL
Ficoll	NULL
,	NULL
6	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
2	NULL
4g	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
,	NULL
where	NULL
indicated	NULL
,	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
either	NULL
non-specific	NULL
or	NULL
specific	NULL
unlabelled	NULL
oligonucleotide	NULL
.	NULL

In	NULL
a	NULL
second	NULL
step	NULL
,	NULL
2	NULL
ul	NULL
of	NULL
radiolabelled	NULL
probe	NULL
was	NULL
added	NULL
to	NULL
each	NULL
sample	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
from	NULL
the	NULL
unbound	NULL
DNA	NULL
probe	NULL
on	NULL
a	NULL
4	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
x	NULL
Tris/borate/EDTA	NULL
buffer	NULL
(	NULL
44	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
44	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
12.5	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
electro-phoreses	NULL
were	NULL
run	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
150	NULL
V/20	NULL
mA	NULL
)	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
were	NULL
:	NULL
Egr-1	NULL
,	NULL
5°	NULL
ATCCCGGCGCGGGG-GCGAGGGCGT	NULL
3	NULL
'	NULL
and	NULL
3	NULL
TAGGGCCGCGCCCCCGCTCC-CGCA	NULL
5	NULL
;	NULL
AP-1	NULL
,	NULL
5	NULL
TTCCGGCTGACTCATCAAGCG	NULL
3	NULL
and	NULL
3	NULL
'	NULL
AAGGCCGACTGAGTAGTTCGC	NULL
5	NULL
.	NULL

RESULTS	NULL
DEM	NULL
treatment	NULL
of	NULL
HL-60	NULL
and	NULL
KG-1	NULL
cells	NULL
prevents	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
differentiated	NULL
phenotype	NULL
induced	NULL
by	NULL
PMA	NULL
We	NULL
were	NULL
interested	NULL
in	NULL
testing	NULL
the	NULL
effects	NULL
of	NULL
redox	NULL
changes	NULL
on	NULL
the	NULL
PMA-induced	NULL
differentiation	NULL
of	NULL
the	NULL
myeloid	NULL
cell	NULL
lines	NULL
HL-60	NULL
and	NULL
KG-1	NULL
that	NULL
can	NULL
be	NULL
monitored	NULL
by	NULL
both	NULL
morphological	NULL
and	NULL
molecular	NULL
approaches	NULL
.	NULL

To	NULL
modify	NULL
the	NULL
intracellular	NULL
redox	NULL
conditions	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
the	NULL
oxidizing	NULL
agent	NULL
DEM	NULL
.	NULL

This	NULL
molecule	NULL
induces	NULL
GSH	NULL
depletion	NULL
by	NULL
acting	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
glutathione	NULL
S-transferase	NULL
,	NULL
which	NULL
catalyses	NULL
the	NULL
formation	NULL
of	NULL
covalently	NULL
linked	NULL
GSH-DEM	NULL
complexes	NULL
[	NULL
16	NULL
]	NULL
.	NULL

GSH	NULL
depletion	NULL
causes	NULL
an	NULL
increase	NULL
in	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
due	NULL
to	NULL
the	NULL
impairment	NULL
of	NULL
antioxidant	NULL
enzyme	NULL
systems	NULL
that	NULL
use	NULL
GSH	NULL
as	NULL
a	NULL
reducing	NULL
agent	NULL
[	NULL
17	NULL
]	NULL
.	NULL

In	NULL
our	NULL
system	NULL
,	NULL
measurement	NULL
of	NULL
intracellular	NULL
GSH	NULL
by	NULL
an	NULL
h.p.l.c.-based	NULL
procedure	NULL
[	NULL
13	NULL
]	NULL
revealed	NULL
a	NULL
rapid	NULL
and	NULL
drastic	NULL
decrease	NULL
in	NULL
the	NULL
GSH	NULL
levels	NULL
in	NULL
response	NULL
to	NULL
DEM	NULL
(	NULL
approx	NULL
.	NULL

70	NULL
%	NULL
decrease	NULL
after	NULL
1	NULL
h	NULL
of	NULL
treatment	NULL
)	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
assessed	NULL
by	NULL
measuring	NULL
Trypan	NULL
Blue	NULL
exclusion	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
treatment	NULL
,	NULL
and	NULL
was	NULL
found	NULL
to	NULL
be	NULL
greater	NULL
than	NULL
80	NULL
%	NULL
regardless	NULL
of	NULL
the	NULL
stimulant	NULL
used	NULL
.	NULL

Under	NULL
our	NULL
experimental	NULL
conditions	NULL
,	NULL
a	NULL
6	NULL
h	NULL
incubation	NULL
with	NULL
PMA	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
HL-60	NULL
proliferation	NULL
(	NULL
measured	NULL
as	NULL
incorporation	NULL
)	NULL
;	NULL
after	NULL
treatment	NULL
with	NULL
DEM	NULL
or	NULL
DEM	NULL
+	NULL
PMA	NULL
,	NULL
a	NULL
significant	NULL
fraction	NULL
(	NULL
approximately	NULL
one-third	NULL
)	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
still	NULL
actively	NULL
proliferating	NULL
.	NULL

One	NULL
of	NULL
the	NULL
clearest	NULL
effects	NULL
of	NULL
PMA	NULL
treatment	NULL
was	NULL
the	NULL
rapid	NULL
attachment	NULL
of	NULL
the	NULL
majority	NULL
(	NULL
>	NULL
70-80	NULL
%	NULL
)	NULL
of	NULL
the	NULL
HL-60	NULL
and	NULL
KG-1	NULL
cells	NULL
,	NULL
which	NULL
normally	NULL
grow	NULL
in	NULL
suspension	NULL
,	NULL
to	NULL
the	NULL
surface	NULL
of	NULL
culture	NULL
dishes	NULL
.	NULL

Stimulation	NULL
of	NULL
adherence	NULL
by	NULL
PMA	NULL
was	NULL
already	NULL
evident	NULL
after	NULL
2-3	NULL
h	NULL
of	NULL
treatment	NULL
,	NULL
and	NULL
persisted	NULL
for	NULL
at	NULL
least	NULL
18-24	NULL
h.	NULL
Addition	NULL
of	NULL
1	NULL
mM	NULL
DEM	NULL
completely	NULL
prevented	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
adherent	NULL
phenotype	NULL
induced	NULL
by	NULL
PMA	NULL
.	NULL

Lower	NULL
concentrations	NULL
of	NULL
DEM	NULL
were	NULL
progressively	NULL
less	NULL
effective	NULL
in	NULL
counteracting	NULL
the	NULL
effect	NULL
of	NULL
PMA	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
well	NULL
established	NULL
molecular	NULL
marker	NULL
of	NULL
HL-60	NULL
and	NULL
KG-1	NULL
differentiation	NULL
is	NULL
the	NULL
repression	NULL
of	NULL
the	NULL
MPO	NULL
[	NULL
5	NULL
]	NULL
and	NULL
CD34	NULL
[	NULL
8	NULL
]	NULL
genes	NULL
respectively	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
of	NULL
these	NULL
transcripts	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
RNA	NULL
from	NULL
HL-60	NULL
and	NULL
KG-1	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
different	NULL
combinations	NULL
of	NULL
DEM	NULL
.	NULL

A	NULL
drastic	NULL
decrease	NULL
in	NULL
both	NULL
the	NULL
MPO	NULL
and	NULL
CD34	NULL
mRNAs	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lanes	NULL
b	NULL
and	NULL
b	NULL
'	NULL
)	NULL
was	NULL
evident	NULL
after	NULL
6h	NULL
of	NULL
exposure	NULL
to	NULL
PMA	NULL
.	NULL

DEM	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
antagonized	NULL
the	NULL
effect	NULL
of	NULL
PMA	NULL
:	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
both	NULL
agents	NULL
(	NULL
lanes	NULL
c	NULL
and	NULL
c	NULL
'	NULL
)	NULL
,	NULL
the	NULL
MPO	NULL
and	NULL
CD34	NULL
mRNA	NULL
levels	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
untreated	NULL
cells	NULL
(	NULL
lanes	NULL
a	NULL
and	NULL
a	NULL
'	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
this	NULL
effect	NULL
of	NULL
DEM	NULL
appeared	NULL
to	NULL
be	NULL
dose-dependent	NULL
and	NULL
lower	NULL
concentrations	NULL
of	NULL
DEM	NULL
(	NULL
0.6	NULL
mM	NULL
,	NULL
lanes	NULL
d	NULL
Research	NULL
Communication	NULL
651	NULL
Figure	NULL
1	NULL
genes	NULL
Effect	NULL
of	NULL
PMA	NULL
and	NULL
DEM	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
MPO	NULL
and	NULL
CD34	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
section	NULL
.	NULL

RNAs	NULL
of	NULL
HL-60	NULL
(	NULL
lanes	NULL
a-e	NULL
)	NULL
and	NULL
KG-1	NULL
(	NULL
lanes	NULL
a'-d	NULL
'	NULL
)	NULL
cells	NULL
were	NULL
analysed	NULL
by	NULL
hybridization	NULL
with	NULL
radiolabelled	NULL
cDNA	NULL
probes	NULL
for	NULL
MPO	NULL
and	NULL
CD34	NULL
respectively	NULL
,	NULL
as	NULL
shown	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
control	NULL
medium	NULL
(	NULL
lane	NULL
a	NULL
)	NULL
,	NULL
10	NULL
nM	NULL
PMA	NULL
(	NULL
lane	NULL
b	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
in	NULL
combination	NULL
with	NULL
DEM	NULL
at	NULL
1	NULL
mM	NULL
(	NULL
lane	NULL
c	NULL
)	NULL
,	NULL
0.6	NULL
mM	NULL
(	NULL
lane	NULL
d	NULL
)	NULL
or	NULL
0.15	NULL
mM	NULL
(	NULL
lane	NULL
e	NULL
)	NULL
.	NULL

DEM	NULL
treatment	NULL
of	NULL
KG-1	NULL
cells	NULL
(	NULL
lanes	NULL
a'-d	NULL
``	NULL
)	NULL
was	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
mM	NULL
and	NULL
0.6	NULL
mM	NULL
for	NULL
6	NULL
h	NULL
(	NULL
lanes	NULL
c	NULL
'	NULL
and	NULL
d	NULL
``	NULL
respectively	NULL
)	NULL
,	NULL
but	NULL
the	NULL
PMA	NULL
concentration	NULL
was	NULL
always	NULL
100	NULL
nM	NULL
.	NULL

A	NULL
photograph	NULL
of	NULL
each	NULL
gel	NULL
(	NULL
bottom	NULL
panels	NULL
)	NULL
is	NULL
shown	NULL
to	NULL
confirm	NULL
that	NULL
equivalent	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
used	NULL
.	NULL

and	NULL
d	NULL
'	NULL
;	NULL
0.15	NULL
mM	NULL
,	NULL
lane	NULL
e	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
the	NULL
amounts	NULL
of	NULL
MPO	NULL
and	NULL
CD34	NULL
mRNAs	NULL
.	NULL

Inhibition	NULL
of	NULL
HL-60	NULL
cells	NULL
differentiation	NULL
by	NULL
DEM	NULL
is	NULL
associated	NULL
with	NULL
abrogation	NULL
of	NULL
PMA-induced	NULL
activation	NULL
of	NULL
AP-1	NULL
and	NULL
Egr-1	NULL
It	NULL
is	NULL
well	NULL
documented	NULL
that	NULL
PMA	NULL
treatment	NULL
induces	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
[	NULL
18	NULL
]	NULL
,	NULL
which	NULL
initiates	NULL
a	NULL
number	NULL
of	NULL
metabolic	NULL
events	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
gene	NULL
expression	NULL
programs	NULL
.	NULL

One	NULL
of	NULL
the	NULL
early	NULL
steps	NULL
in	NULL
this	NULL
process	NULL
is	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
,	NULL
which	NULL
consists	NULL
of	NULL
a	NULL
heterodimeric	NULL
complex	NULL
of	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
[	NULL
19	NULL
]	NULL
.	NULL

Since	NULL
the	NULL
monocytic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
and	NULL
KG-1	NULL
cells	NULL
is	NULL
triggered	NULL
by	NULL
PMA	NULL
,	NULL
we	NULL
studied	NULL
whether	NULL
DEM	NULL
treatment	NULL
could	NULL
affect	NULL
the	NULL
DNA-binding	NULL
capacity	NULL
of	NULL
AP-1	NULL
.	NULL

Figure	NULL
2	NULL
(	NULL
a	NULL
)	NULL
shows	NULL
the	NULL
EMSA	NULL
of	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
TRE	NULL
,	NULL
which	NULL
represents	NULL
the	NULL
DNA	NULL
cis-element	NULL
interacting	NULL
with	NULL
AP-1	NULL
.	NULL

When	NULL
this	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
HL-60	NULL
cells	NULL
,	NULL
a	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
appeared	NULL
following	NULL
PMA	NULL
treatment	NULL
(	NULL
lanes	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

Exposure	NULL
to	NULL
DEM	NULL
+	NULL
PMA	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
this	NULL
complex	NULL
(	NULL
lane	NULL
d	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
additional	NULL
steps	NULL
of	NULL
the	NULL
HL-60	NULL
and	NULL
KG-1	NULL
cell	NULL
differentiation	NULL
pathways	NULL
may	NULL
be	NULL
compromised	NULL
by	NULL
GSH	NULL
depletion	NULL
.	NULL

It	NULL
was	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
Egr-1	NULL
is	NULL
essential	NULL
for	NULL
HL-60	NULL
differentiation	NULL
along	NULL
the	NULL
monocytic	NULL
lineage	NULL
[	NULL
12	NULL
]	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
Egr-1	NULL
is	NULL
an	NULL
early	NULL
event	NULL
,	NULL
and	NULL
therefore	NULL
it	NULL
could	NULL
be	NULL
independent	NULL
from	NULL
AP-1	NULL
activation	NULL
.	NULL

EMSA	NULL
of	NULL
Egr-1	NULL
oligonucleotides	NULL
,	NULL
incubated	NULL
with	NULL
the	NULL
same	NULL
extracts	NULL
used	NULL
for	NULL
AP-1	NULL
evaluation	NULL
,	NULL
demonstrated	NULL
an	NULL
Egr-l-specific	NULL
band	NULL
present	NULL
in	NULL
PMA-treated	NULL
HL-60	NULL
cells	NULL
(	NULL
Figure	NULL
2b	NULL
,	NULL
lane	NULL
c	NULL
)	NULL
,	NULL
but	NULL
this	NULL
was	NULL
absent	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
both	NULL
DEM	NULL
and	NULL
PMA	NULL
(	NULL
lane	NULL
d	NULL
)	NULL
.	NULL

The	NULL
same	NULL
extracts	NULL
were	NULL
analysed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
C/EBP	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
remain	NULL
unaffected	NULL
by	NULL
Figure	NULL
2	NULL
-	NULL
Effects	NULL
of	NULL
DEM	NULL
on	NULL
DNA	NULL
binding	NULL
of	NULL
AP-1	NULL
and	NULL
Egr-1	NULL
in	NULL
HL-60	NULL
cells	NULL
(	NULL
@	NULL
)	NULL
AP-1	NULL
EMSA	NULL
.	NULL

Lane	NULL
a	NULL
,	NULL
labelled	NULL
TRE	NULL
oligonucleotide	NULL
without	NULL
extracts	NULL
;	NULL
lanes	NULL
b-e	NULL
,	NULL
labelled	NULL
TRE	NULL
oligonucleotide	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
HL-60	NULL
cells	NULL
(	NULL
lane	NULL
b	NULL
)	NULL
,	NULL
or	NULL
HL-60	NULL
cells	NULL
treated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
10	NULL
nM	NULL
PMA	NULL
(	NULL
lane	NULL
c	NULL
)	NULL
,	NULL
10	NULL
nM	NULL
PMA+1	NULL
mM	NULL
DEM	NULL
(	NULL
lane	NULL
d	NULL
)	NULL
or	NULL
1	NULL
mM	NULL
DEM	NULL
alone	NULL
(	NULL
lane	NULL
e	NULL
)	NULL
.	NULL

in	NULL
lanes	NULL
f	NULL
and	NULL
g	NULL
,	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
untreated	NULL
HL-60	NULL
cells	NULL
was	NULL
preincubated	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
TRE	NULL
oligonucleotide	NULL
or	NULL
of	NULL
unlabelled	NULL
non-specific	NULL
competitor	NULL
oligonucleotide	NULL
respectively	NULL
.	NULL

(	NULL
I	NULL
)	NULL
Egr-1	NULL
EMSA	NULL
.	NULL

Lane	NULL
a	NULL
,	NULL
labelled	NULL
Egr-1	NULL
oligonucteotide	NULL
without	NULL
extracts	NULL
;	NULL
lanes	NULL
b-e	NULL
,	NULL
as	NULL
in	NULL
(	NULL
a	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
f	NULL
and	NULL
g	NULL
,	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
untreated	NULL
HL-60	NULL
cells	NULL
was	NULL
preincubated	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
Egr-1	NULL
oligonucleotide	NULL
or	NULL
of	NULL
unlabelled	NULL
non-specific	NULL
competitor	NULL
oligonucleotide	NULL
respectively	NULL
.	NULL

Figure	NULL
3	NULL
-	NULL
Effects	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
treatment	NULL
on	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
Egr-1	NULL
Labelled	NULL
Egr-1	NULL
oligonucleotide	NULL
was	NULL
electrophoresed	NULL
after	NULL
a	NULL
30	NULL
min	NULL
incubation	NULL
on	NULL
ice	NULL
with	NULL
:	NULL
lane	NULL
a	NULL
,	NULL
no	NULL
extracts	NULL
;	NULL
lane	NULL
b	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA-treated	NULL
HL-60	NULL
cells	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA-treated	NULL
HL-60	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
mM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

redox	NULL
changes	NULL
[	NULL
20	NULL
]	NULL
;	NULL
identical	NULL
amounts	NULL
of	NULL
C/EBP	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
samples	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
impairment	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
Egr-1	NULL
could	NULL
be	NULL
the	NULL
direct	NULL
result	NULL
of	NULL
oxidation	NULL
of	NULL
this	NULL
factor	NULL
;	NULL
we	NULL
tested	NULL
this	NULL
possibility	NULL
by	NULL
treating	NULL
in	NULL
vitro	NULL
the	NULL
same	NULL
extracts	NULL
used	NULL
for	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Figures	NULL
2	NULL
(	NULL
a	NULL
)	NULL
and	NULL
2	NULL
(	NULL
b	NULL
)	NULL
(	NULL
lane	NULL
e	NULL
)	NULL
with	NULL
20	NULL
mM	NULL
H,0	NULL
,	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Egr-1	NULL
to	NULL
bind	NULL
to	NULL
its	NULL
target	NULL
DNA	NULL
sequence	NULL
was	NULL
abolished	NULL
following	NULL
incubation	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
C/EBP	NULL
,	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
remained	NULL
unaffected	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

652	NULL
Research	NULL
Communication	NULL
Figure	NULL
4	NULL
-	NULL
Recovery	NULL
of	NULL
AP-1	NULL
DNA	NULL
binding	NULL
after	NULL
removal	NULL
of	NULL
DEM	NULL
The	NULL
labelled	NULL
TRE	NULL
oligonucleotide	NULL
was	NULL
electrophoresed	NULL
after	NULL
incubation	NULL
with	NULL
:	NULL
lane	NULL
1	NULL
,	NULL
no	NULL
extracts	NULL
;	NULL
lane	NULL
b	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
HL-60	NULL
cells	NULL
treated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
10	NULL
nM	NULL
PMA	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
treated	NULL
for	NULL
6h	NULL
with	NULL
10	NULL
nM	NULL
PMA+1	NULL
mM	NULL
DEM	NULL
;	NULL
lanes	NULL
d	NULL
and	NULL
e	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
treated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
PMA	NULL
alone	NULL
or	NULL
PMA-+	NULL
DEM	NULL
respectively	NULL
,	NULL
extensively	NULL
washed	NULL
to	NULL
remove	NULL
the	NULL
stimuli	NULL
from	NULL
the	NULL
medium	NULL
and	NULL
harvested	NULL
24	NULL
h	NULL
later	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
effect	NULL
of	NULL
DEM	NULL
is	NULL
reversible	NULL
,	NULL
and	NULL
to	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
of	NULL
aspecific	NULL
cellular	NULL
toxicity	NULL
,	NULL
HL-60	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
alone	NULL
or	NULL
PMA	NULL
+	NULL
DEM	NULL
for	NULL
6h	NULL
,	NULL
washed	NULL
and	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
h	NULL
in	NULL
control	NULL
medium	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
even	NULL
without	NULL
re-addition	NULL
of	NULL
PMA	NULL
,	NULL
an	NULL
almost	NULL
complete	NULL
recovery	NULL
of	NULL
AP-1	NULL
DNA-binding	NULL
efficiency	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
extracts	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
+	NULL
DEM	NULL
(	NULL
Figure	NULL
4	NULL
;	NULL
compare	NULL
lanes	NULL
c	NULL
and	NULL
e	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Many	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
sensitive	NULL
to	NULL
redox	NULL
changes	NULL
in	NULL
vitro	NULL
;	NULL
this	NULL
phenomenon	NULL
was	NULL
observed	NULL
for	NULL
AP-1	NULL
[	NULL
21	NULL
]	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
[	NULL
22	NULL
]	NULL
,	NULL
USF	NULL
[	NULL
23	NULL
]	NULL
,	NULL
HoxB5	NULL
[	NULL
24	NULL
]	NULL
,	NULL
BZFL	NULL
1	NULL
[	NULL
20	NULL
]	NULL
and	NULL
for	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
[	NULL
25	NULL
]	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
these	NULL
observations	NULL
in	NULL
vivo	NULL
is	NULL
still	NULL
to	NULL
be	NULL
demonstrated	NULL
,	NULL
although	NULL
several	NULL
pieces	NULL
of	NULL
evidence	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
in	NULL
vive	NULL
changes	NULL
in	NULL
intracellular	NULL
redox	NULL
conditions	NULL
may	NULL
result	NULL
in	NULL
modifications	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
[	NULL
21,26-28	NULL
]	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
complex	NULL
machinery	NULL
that	NULL
regulates	NULL
the	NULL
redox	NULL
status	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
[	NULL
29-31	NULL
]	NULL
,	NULL
and	NULL
of	NULL
another	NULL
enzymic	NULL
apparatus	NULL
that	NULL
controls	NULL
intracellular	NULL
redox	NULL
conditions	NULL
[	NULL
32	NULL
]	NULL
,	NULL
favours	NULL
the	NULL
hypothesis	NULL
that	NULL
oxidation	NULL
or	NULL
reduction	NULL
of	NULL
DNA-binding	NULL
factors	NULL
may	NULL
affect	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
direct	NULL
evidence	NULL
that	NULL
redox	NULL
changes	NULL
may	NULL
in	NULL
fact	NULL
affect	NULL
gene	NULL
expression	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
produced	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
we	NULL
demonstrate	NULL
that	NULL
redox	NULL
modifications	NULL
induced	NULL
by	NULL
DEM	NULL
dramatically	NULL
affect	NULL
the	NULL
PMA-driven	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
reversal	NULL
of	NULL
morphological	NULL
and	NULL
molecular	NULL
signs	NULL
of	NULL
differentiation	NULL
,	NULL
including	NULL
the	NULL
repression	NULL
of	NULL
the	NULL
CD34	NULL
and	NULL
MPO	NULL
genes	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
phenomenon	NULL
could	NULL
reside	NULL
in	NULL
alterations	NULL
in	NULL
the	NULL
behaviour	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
PMA-dependent	NULL
differentiation	NULL
pathways	NULL
,	NULL
due	NULL
to	NULL
the	NULL
oxidizing	NULL
environment	NULL
generated	NULL
by	NULL
GSH	NULL
depletion	NULL
.	NULL

Two	NULL
transcription	NULL
factors	NULL
were	NULL
examined	NULL
:	NULL
AP-1	NULL
,	NULL
a	NULL
well	NULL
known	NULL
target	NULL
of	NULL
the	NULL
PMA-induced	NULL
protein	NULL
kinase	NULL
C	NULL
cascade	NULL
[	NULL
19	NULL
]	NULL
,	NULL
and	NULL
Egr-1	NULL
,	NULL
which	NULL
was	NULL
recently	NULL
demonstrated	NULL
to	NULL
be	NULL
an	NULL
important	NULL
mediator	NULL
of	NULL
myeloid	NULL
differentiation	NULL
[	NULL
12	NULL
]	NULL
.	NULL

That	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
is	NULL
sensitive	NULL
to	NULL
redox	NULL
changes	NULL
is	NULL
a	NULL
well	NULL
demonstrated	NULL
phenomenon	NULL
[	NULL
21	NULL
]	NULL
.	NULL

The	NULL
results	NULL
reported	NULL
here	NULL
,	NULL
indicating	NULL
that	NULL
DEM	NULL
treatment	NULL
prevents	NULL
the	NULL
enhancement	NULL
of	NULL
AP-1	NULL
DNA	NULL
binding	NULL
caused	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
,	NULL
further	NULL
confirm	NULL
and	NULL
extend	NULL
these	NULL
previous	NULL
observations	NULL
.	NULL

Egr-1	NULL
activation	NULL
was	NULL
similarly	NULL
inhibited	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
HL-60	NULL
cells	NULL
exposed	NULL
to	NULL
PMA	NULL
and	NULL
DEM	NULL
,	NULL
compared	NULL
with	NULL
those	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
alone	NULL
.	NULL

This	NULL
could	NULL
be	NULL
a	NULL
consequence	NULL
either	NULL
of	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
leading	NULL
to	NULL
Egr-1	NULL
activation	NULL
or	NULL
of	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
the	NULL
oxidizing	NULL
environment	NULL
on	NULL
this	NULL
transcription	NULL
factor	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
Egr-1	NULL
DNA	NULL
binding	NULL
is	NULL
abolished	NULL
by	NULL
treatment	NULL
of	NULL
nuclear	NULL
extracts	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
in	NULL
vitro	NULL
supports	NULL
the	NULL
hypothesis	NULL
of	NULL
a	NULL
direct	NULL
sensitivity	NULL
of	NULL
Egr-1	NULL
to	NULL
redox	NULL
alterations	NULL
in	NULL
the	NULL
intact	NULL
cells	NULL
.	NULL

The	NULL
intracellular	NULL
redox	NULL
conditions	NULL
are	NULL
the	NULL
result	NULL
of	NULL
the	NULL
equilibrium	NULL
between	NULL
the	NULL
production	NULL
of	NULL
oxidizing	NULL
radicals	NULL
,	NULL
which	NULL
occurs	NULL
in	NULL
many	NULL
metabolic	NULL
reactions	NULL
(	NULL
mitochondrial	NULL
electron	NULL
transfer	NULL
,	NULL
arachidonate	NULL
metabolism	NULL
and	NULL
peroxisomal	NULL
reactions	NULL
)	NULL
,	NULL
and	NULL
their	NULL
inactivation	NULL
catalysed	NULL
by	NULL
a	NULL
complex	NULL
enzyme	NULL
system	NULL
[	NULL
32	NULL
]	NULL
.	NULL

A	NULL
number	NULL
of	NULL
situations	NULL
are	NULL
known	NULL
in	NULL
which	NULL
intracellular	NULL
concentrations	NULL
of	NULL
oxidizing	NULL
radicals	NULL
are	NULL
increased	NULL
.	NULL

These	NULL
include	NULL
exposure	NULL
to	NULL
u.v.-B	NULL
light	NULL
or	NULL
y	NULL
rays	NULL
,	NULL
binding	NULL
of	NULL
extracellular	NULL
ligands	NULL
to	NULL
their	NULL
membrane	NULL
receptors	NULL
[	NULL
31	NULL
]	NULL
and	NULL
reperfusion	NULL
of	NULL
hypoxic	NULL
cells	NULL
[	NULL
33	NULL
]	NULL
.	NULL

In	NULL
some	NULL
of	NULL
these	NULL
cases	NULL
,	NULL
modifications	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
genes	NULL
were	NULL
observed	NULL
,	NULL
such	NULL
as	NULL
inhibition	NULL
of	NULL
tumour	NULL
necrosis	NULL
factor	NULL
biosynthesis	NULL
[	NULL
34	NULL
]	NULL
,	NULL
overproduction	NULL
of	NULL
interleukin-1	NULL
[	NULL
35,36	NULL
]	NULL
or	NULL
interleukin-8	NULL
[	NULL
37	NULL
]	NULL
,	NULL
and	NULL
enhancement	NULL
of	NULL
HIV-1	NULL
transcription	NULL
[	NULL
38,39	NULL
]	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
this	NULL
is	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and/or	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
due	NULL
to	NULL
oxidant	NULL
stress	NULL
[	NULL
28,40	NULL
]	NULL
.	NULL

In	NULL
the	NULL
light	NULL
of	NULL
these	NULL
data	NULL
,	NULL
our	NULL
observation	NULL
that	NULL
GSH	NULL
depletion	NULL
in	NULL
intact	NULL
cells	NULL
interferes	NULL
with	NULL
the	NULL
myeloid	NULL
differentiation	NULL
driven	NULL
by	NULL
PMA	NULL
suggests	NULL
that	NULL
this	NULL
maturation	NULL
pathway	NULL
may	NULL
be	NULL
modulated	NULL
by	NULL
different	NULL
stimuli	NULL
that	NULL
induce	NULL
an	NULL
increase	NULL
in	NULL
reactive	NULL
oxygen	NULL
radicals	NULL
.	NULL

To	NULL
gain	NULL
additional	NULL
insight	NULL
into	NULL
this	NULL
matter	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
considerable	NULL
interest	NULL
to	NULL
investigate	NULL
the	NULL
possible	NULL
alterations	NULL
in	NULL
myeloid	NULL
differentiation	NULL
associated	NULL
with	NULL
physiological	NULL
conditions	NULL
known	NULL
to	NULL
affect	NULL
the	NULL
intracellular	NULL
redox	NULL
status	NULL
,	NULL
such	NULL
as	NULL
ageing	NULL
.	NULL

In	NULL
this	NULL
situation	NULL
an	NULL
increase	NULL
in	NULL
oxidizing	NULL
radicals	NULL
is	NULL
well	NULL
documented	NULL
[	NULL
41	NULL
]	NULL
,	NULL
and	NULL
we	NULL
have	NULL
observed	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Spl	NULL
[	NULL
42	NULL
]	NULL
in	NULL
old	NULL
animals	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
H.	NULL
M.	NULL
Bond	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
and	NULL
Dr.	NULL
M.	NULL
A.	NULL
Belisario	NULL
for	NULL
h.p.1.c	NULL
.	NULL

determination	NULL
of	NULL
GSH	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
CNR	NULL
Special	NULL
Projects	NULL
'Invecchiamento	NULL
'	NULL
,	NULL
'ACRO	NULL
'	NULL
and	NULL
'Ingegneria	NULL
Genetica	NULL
'	NULL
,	NULL
from	NULL
AIRC	NULL
,	NULL
ISS	NULL
Progetto	NULL
AIDS	NULL
,	NULL
and	NULL
MURST	NULL
40	NULL
%	NULL
and	NULL
60	NULL
%	NULL
.	NULL

REFERENCES	NULL
1	NULL
-	NULL
Metcalf	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
339	NULL
,	NULL
27-30	NULL
2	NULL
-	NULL
Lilbbert	NULL
,	NULL
M.	NULL
,	NULL
Hermann	NULL
,	NULL
F.	NULL
and	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
909-924	NULL
3	NULL
-	NULL
Collins	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Ruscetti	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Gallagher	NULL
,	NULL
R.	NULL
E.	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1978	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
75	NULL
,	NULL
2458-2462	NULL
4	NULL
-	NULL
Rovera	NULL
,	NULL
G.	NULL
,	NULL
O'Brien	NULL
,	NULL
T.	NULL
G.	NULL
and	NULL
Diamond	NULL
,	NULL
L.	NULL
(	NULL
1979	NULL
)	NULL
Science	NULL
204	NULL
,	NULL
868-870	NULL
Sagoh	NULL
,	NULL
T.	NULL
and	NULL
Yamada	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

262	NULL
,	NULL
599-604	NULL
Chung	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Kershaw	NULL
,	NULL
S.	NULL
and	NULL
Gordon	NULL
,	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
85	NULL
,	NULL
6227-6231	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
and	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1978	NULL
)	NULL
Science	NULL
200	NULL
,	NULL
1153-1154	NULL
Satterthwaite	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Borson	NULL
,	NULL
R.	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Blood	NULL
75	NULL
,	NULL
2299-2304	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
575-581	NULL
Green	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
DeLuca	NULL
,	NULL
E.	NULL
and	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
4153-4158	NULL
Kreider	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Benezra	NULL
,	NULL
R.	NULL
,	NULL
Rovera	NULL
,	NULL
G.	NULL
and	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
255	NULL
,	NULL
1700-1702	NULL
12	NULL
-	NULL
Nguyen	NULL
,	NULL
H.	NULL
Q.	NULL
,	NULL
Hoffmann-Liebermann	NULL
,	NULL
B.	NULL
and	NULL
Liebermann	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
72	NULL
,	NULL
197-209	NULL
13	NULL
-	NULL
Reed	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Babson	NULL
,	NULL
J.	NULL
R	NULL
,	NULL
Beatty	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Brodie	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Ellis	NULL
,	NULL
W.	NULL
W.	NULL
and	NULL
Potter	NULL
,	NULL
D.	NULL
(	NULL
1980	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

106	NULL
,	NULL
55-62	NULL
14	NULL
-	NULL
Chomczysnky	NULL
,	NULL
P.	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
15	NULL
-	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
16	NULL
-	NULL
Boyland	NULL
,	NULL
E.	NULL
and	NULL
Chasseaud	NULL
,	NULL
L.	NULL
F.	NULL
(	NULL
1970	NULL
)	NULL
Biochem	NULL
.	NULL

Pharmacol	NULL
.	NULL

19	NULL
,	NULL
1526-1528	NULL
17	NULL
-	NULL
Meister	NULL
,	NULL
A.	NULL
and	NULL
Anderson	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1983	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

§2	NULL
,	NULL
711-760	NULL
o	NULL
on	NULL
wa	NULL
_s	NULL
--	NULL
C	NULL
&	NULL
«	NULL
co	NULL
w	NULL
Research	NULL
Communication	NULL
653	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
29	NULL
30	NULL
31	NULL
Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
308	NULL
,	NULL
693-698	NULL
Curran	NULL
,	NULL
T.	NULL
and	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
395-397	NULL
Bannister	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Cook	NULL
,	NULL
A.	NULL
and	NULL
Kouzarides	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
1243-1250	NULL
Abate	NULL
,	NULL
C.	NULL
,	NULL
Patel	NULL
,	NULL
L.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
If	NULL
!	NULL

and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1157-1161	NULL
Toledano	NULL
,	NULL
M.	NULL
B.	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
88	NULL
,	NULL
4328-4332	NULL
Pognonec	NULL
,	NULL
P.	NULL
,	NULL
Kato	NULL
,	NULL
H.	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
24563-24567	NULL
Galang	NULL
,	NULL
C.	NULL
K.	NULL
and	NULL
Hauser	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
4609-4717	NULL
Tienrungroj	NULL
,	NULL
W.	NULL
,	NULL
Meschinchi	NULL
,	NULL
S.	NULL
,	NULL
Sanchez	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Pratt	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Grippo	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Holmgren	NULL
,	NULL
A.	NULL
and	NULL
Pratt	NULL
,	NULL
W.	NULL
B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
6992-7000	NULL
Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
Miao	NULL
,	NULL
G.	NULL
,	NULL
Wang	NULL
,	NULL
F.	NULL
,	NULL
Pan	NULL
,	NULL
Y.	NULL
E.	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
3323-3335	NULL
Kumar	NULL
,	NULL
S.	NULL
,	NULL
Rabson	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
and	NULL
Gelinas	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3094-3106	NULL
Meyer	NULL
,	NULL
M.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
and	NULL
Bauerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2005-2015	NULL
Rushmore	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Morton	NULL
,	NULL
M.	NULL
R.	NULL
and	NULL
Pickett	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
11632-11639	NULL
Li	NULL
,	NULL
Y.	NULL
and	NULL
Jaiswal	NULL
,	NULL
A.	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
15097-15104	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Albermann	NULL
,	NULL
K.	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Free	NULL
Radicals	NULL
Res	NULL
.	NULL

Commun	NULL
.	NULL

17	NULL
,	NULL
221-237	NULL
Received	NULL
9	NULL
May	NULL
1994	NULL
;	NULL
accepted	NULL
18	NULL
May	NULL
1994	NULL
32	NULL
33	NULL
34	NULL
35	NULL
36	NULL
37	NULL
38	NULL
39	NULL
40	NULL
41	NULL
Freeman	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
and	NULL
Crapo	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1982	NULL
)	NULL
Lab	NULL
.	NULL

Invest	NULL
.	NULL

47	NULL
,	NULL
412-426	NULL
Zweier	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Kuppusamy	NULL
,	NULL
P.	NULL
and	NULL
Lutty	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
85	NULL
,	NULL
4046-4050	NULL
Israel	NULL
,	NULL
N.	NULL
,	NULL
Gougerot-Pocidalo	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Aillet	NULL
,	NULL
F.	NULL
and	NULL
Virelizier	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
3386-3393	NULL
Ghezzi	NULL
,	NULL
P.	NULL
,	NULL
Dinarello	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Bianchi	NULL
,	NULL
M.	NULL
,	NULL
Rosandich	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Repine	NULL
,	NULL
J.	NULL
E.	NULL
and	NULL
White	NULL
,	NULL
C.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Cytokine	NULL
3	NULL
,	NULL
189-194	NULL
Koga	NULL
,	NULL
S.	NULL
,	NULL
Ogawa	NULL
,	NULL
S.	NULL
,	NULL
Kuwabara	NULL
,	NULL
K.	NULL
,	NULL
Brett	NULL
,	NULL
J.	NULL
,	NULL
Leavy	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Ryan	NULL
,	NULL
J.	NULL
,	NULL
Koga	NULL
,	NULL
Y.	NULL
,	NULL
Plocinsky	NULL
,	NULL
J.	NULL
,	NULL
Benjamin	NULL
,	NULL
W.	NULL
,	NULL
Burns	NULL
,	NULL
D.	NULL
K.	NULL
and	NULL
Stern	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90	NULL
,	NULL
1007-1015	NULL
DeForge	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Preston	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Tacheuchi	NULL
,	NULL
E.	NULL
,	NULL
Kenney	NULL
,	NULL
J.	NULL
,	NULL
Boxer	NULL
,	NULL
L.	NULL
A.	NULL
and	NULL
Remick	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
25568-25576	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Staal	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Raju	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Ela	NULL
,	NULL
S.	NULL
W.	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
87	NULL
,	NULL
4884-4888	NULL
Staal	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Roederer	NULL
,	NULL
M.	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
87	NULL
,	NULL
9943-9947	NULL
Menon	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Qin	NULL
,	NULL
S.	NULL
,	NULL
Guy	NULL
,	NULL
G.	NULL
E.	NULL
and	NULL
Tan	NULL
,	NULL
Y.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
26805-26812	NULL
Stadtman	NULL
,	NULL
E.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
1220-1224	NULL
Ammendola	NULL
,	NULL
R.	NULL
,	NULL
Mesuraca	NULL
,	NULL
M.	NULL
,	NULL
Russo	NULL
,	NULL
T.	NULL
and	NULL
Cimino	NULL
,	NULL
F.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
17944-17948	NULL

